Barchart.com
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Wave Life Sci Ord Sh (WVE)

Wave Life Sci Ord Sh (WVE)
6.77 -0.02 (-0.29%) 09:37 ET [NASDAQ]
6.67 x 100 6.82 x 100
Realtime by (Cboe BZX)
6.67 x 100 6.82 x 100
Realtime 7.12 +0.33 (+4.86%) 08:20 ET
News & Headlines for Thu, Apr 24th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531 GlobeNewswire - Wed Mar 26, 6:30AM CDT

WVE : 6.77 (-0.29%)
Wave Life Sciences: Q4 Earnings Snapshot AP - Tue Mar 4, 6:52AM CST

Wave Life Sciences: Q4 Earnings Snapshot

WVE : 6.77 (-0.29%)
Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update GlobeNewswire - Tue Mar 4, 6:30AM CST

WVE : 6.77 (-0.29%)
Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025 GlobeNewswire - Tue Feb 25, 7:30AM CST

WVE : 6.77 (-0.29%)
Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity GlobeNewswire - Thu Feb 6, 7:30AM CST

WVE : 6.77 (-0.29%)
Wave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan Presentation GlobeNewswire - Mon Jan 13, 8:00AM CST

WVE : 6.77 (-0.29%)
Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity GlobeNewswire - Mon Dec 23, 2024

WVE : 6.77 (-0.29%)
Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference GlobeNewswire - Mon Dec 16, 2024

WVE : 6.77 (-0.29%)
Insider Sale: President and CEO of $WVE (WVE) Sells 50,000 Shares Quiver Quantitative, Inc. - Thu Nov 28, 2024

PAUL BOLNO, the President and CEO of $WVE ($WVE), sold 50,000 shares of the company on 11-25-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 18.7% of their...

WVE : 6.77 (-0.29%)
Wave Life Sciences to Present at Upcoming Investor Conferences GlobeNewswire - Tue Nov 26, 2024

WVE : 6.77 (-0.29%)

Barchart Exclusives

The Sentiment Genome: BSX Stock Could Be Entering a High-Probability Setup Barchart - 26 minutes ago
With the market signaling a hot deck, risk-tolerant speculators will want to keep close tabs on BSX stock over the next week. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot